Back

Stroke, thromboembolism and bleeding events in patients with atrial fibrillation according to the new EHRA valvular heart disease classification

19 March 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 2 - Atrial fibrillation - Clinical Stroke in Atrial Fibrillation EHRA Premium Access EHRA 2018

About the speaker

Photo
Professor Arnaud Bisson

CHU de Tours, Tours (France)

13 More presentations in this session

Presentation thumbnail
Professor A. Ben Halima (Tunis, TN)
Abstract Slides
Presentation thumbnail
Professor J. Hendriks (Maastricht, NL)
Abstract Slides
Presentation thumbnail
Doctor O. Tica (Oradea, RO)
Abstract
Presentation thumbnail
Doctor D. Candeias Faria (Faro, PT)
Abstract Slides
Presentation thumbnail
Doctor E. Garcia-Izquierdo Jaen (Majadahonda, ES)
Abstract

Access the full session

Session thumbnail
Poster session 2 - Atrial fibrillation - Clinical

The Event

Event poster

EHRA 2018

19 March 2018 00:00 CET
You may be interested in
thumbnail
Congress Presentation
Clinical and prognosis assessment of Atrial Fibrillation patients with significant valvular disease. Validation of the EHRA valve classification (Evaluated Heartvalves. Rheumatic or Artificial)
29 August 2022
thumbnail
Webinar
Balancing stroke and bleeding risks in patients with AF and concomitant coronary artery disease, malignancy, chronic kidney disease, or frailty
10 November 2025
thumbnail
Congress Presentation
Incidence of cardiovascular events in patients with atrial fibrillation anticoagulated with rivaroxaban after 2.5 years of follow-up: not all is stroke or bleeding
27 August 2021
thumbnail
Congress Presentation
Atrial fibrillation: the difference in thromboembolic events prognosis
19 March 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources